The influence of medium-chain glycerides on performance and gastrointestinal wellbeing in weaning piglets was assessed. First, caproic (C6), caprylic (C8) and capric (C10) acid activity against Escherichia coli was screened in vitro. Pig flora of the whole small intestine was used as inoculum. Seven in vitro incubations were done in duplicate at pH = 3 and 5: C10 (15 mM), C8 (12 mM), C6 (15, 12, 10 mM), a non-incubatednegative control and incubated negative control. Culture suspensions were plated on E. coli-selective agar. Controls showed bacterial growth. C6 and C8 showed no growth at both pH-values, where C10 showed growth at pH = 5. Secondly, an in vivo study was done with 80 weaned piglets over 42 days, housed in pens of eight animals (five pens/treatment), fed a basal diet containing broken rice/soya bean meal/fish meal and supplemented with C6 and C8 in medium-chain glyceride form (MCT6/8, 0.175%) or antibiotic growth promoter (AGP, 0.020%) (Kasetsart University, Thailand) serving as control. Feed intake, daily gain and feed-to-gain ratio did not differ be- 
| INTRODUC TI ON
Weaning is a critical event in a piglet's life due to stress of social, nutritional and environmental nature. This period of transition is accompanied with altered immune responses (Bomba et al., 2014; Niekamp, Sutherland, Dahl, & Salak-Johnson, 2007) , a drop in feed intake and anatomical and functional changes in the gut resulting in a lower digestive capacity (Nuñez et al., 1996; Pluske, Hampson, & Williams, 1997) . Hence, post-weaning diarrhoea is common and most often due to an overgrowth of enterotoxigenic Escherichia coli (ETEC) (Hopwood, Pluske, & Hampson, 2006; Moonens et al., 2015) .
The use of anti-microbials to support post-weaning piglet performance has become restricted. Where anti-microbial growth promoters (AGP) have been banned since 2006 in the EU, more recently also the preventive and therapeutic usage is under pressure (e.g., AMCRA Convenant, Outlook 2020 , Belgium, EU, 2015 . In 2003, medium-chain glycerides (MCG) were proposed as a promising alternative for in-feed antibiotics to protect gastrointestinal health and immunity of weaned piglets Dierick, Decuypere, & Degeyter, 2003; Dierick, Decuypere, Molly, Beek, & Vanderbeke, 2002a, b) .
MCG are defined as esters of glycerol and medium-chain fatty acids, which are fatty acids with carbon chain lengths from 6 to 12 atoms (Dierick et al., 2002a) . MCG, in contrast to the free fatty acids, have inherent "slow release" properties without a repellent smell or taste (Messens, Goris, Dierick, Herman, & Heyndrickx, 2010; Zentek et al., 2011) . This is a concept originating from nature, for example, milk lipids that are converted to mono-glycerides and fatty acids by lingual/gastric lipase in suckling neonates. Such lipids serve as a defence system against microbial infections at the gut mucosa (Isaacs, 2001 ).
There is evidence from in vitro studies that the anti-microbial activity varies amongst medium-chain fatty acids (Dierick et al., 2002a) .
It is also shown that C6 and C8 act stronger against Salmonella than C10 (Boyen et al., 2008; Messens et al., 2010; Van Immerseel et al., 2004; Vasudevan et al., 2005) . The in vitro action of C6, C8 and C10 against other Gram-negative bacteria such as the most important disease causing agent in post-weaning piglets, enterotoxigenic Escherichia coli, was not assessed.
In vivo, the degree of C8 and C10 hydrolysis from glycerol using supplemental exogenous lipase is positively correlated with E. coli suppression in weaning piglets' stomach and duodenum (Dierick, Decuypere, Molly, Beek, & Vanderbeke, 2002b) . The in vivo effects of MCG containing C6 and C8 against E. coli are not known yet. Furthermore, it is shown that also in the absence of exogenous lipase, post-weaning piglet gastric and pancreatic lipase, in combination with endogenous lipases present in some feedstuffs (Dierick & Decuypere, 2002) , sufficiently release active molecules (mono-glycerides and free fatty acids) of MCG (Ghent University and AVEVE Biochem NV, unpublished research).
In the present study, the antibacterial action of C6, C8 and C10 was first verified in vitro as a rapid screening of most potent antibacterial molecules against E. coli. Medium-chain fatty acids that reduced E. coli best in vitro were then selected for the in vivo part of the study. These medium-chain fatty acids were orally administered in a glyceride form (MCG) to piglets that were experimentally challenged with E. coli-derived lipopolysaccharide (LPS). A comparison was made with piglets receiving an antibiotic growth promoter (AGP). AGP is the standard treatment against post-weaning piglet diarrhoea in the region and country where the in vivo study was carried out (Thailand). Piglet performance and intestinal health parameters were studied as follows: villus height, crypt depth, serum IgA and IgA-positive plasma cells and goblet cells. This work may offer new insights in healthy and non-medicated post-weaning piglet farming practices.
| MATERIAL S AND ME THODS

| In vitro analysis
The trial was performed at the Ghent University Department of Animal Production (Ghent University, Belgium). On the day of the experiment, two piglets (live weight about 20 kg), fed a compound corn/soya bean meal-based diet without AGP and formulated to contain maximum EU levels of Cu (25 mg/kg feed) and Zn (150 mg/ kg feed), were euthanized. The gastrointestinal tract was removed, and the contents of the whole small intestine were collected quantitatively, pooled and centrifuged (1,500 g, 10 min, 5°C) to remove residual feed and debris. The supernatant that contained a suspension of the luminal flora was used as inoculum.
A synthetic feed was made, based on corn starch, dextrose, casein, casein hydrolysate, soya oil, bile acids, fibre and vitamins and minerals. Glycine (pH=3) and phosphate buffer (pH = 5) were used to mimic gastric, respectively, duodenal conditions (Dierick et al., 2002a) . Fatty acids C6, C8 or C10 (provided by AVEVE Biochem NV, Merksem, Belgium) were added to 100 ml of buffer solution that was pre-heated to 37°C. In total, seven treatments were carried out in duplicate: incubations of C10 (15 mM), C8 (12 mM), C6 (15 mM, 12 mM or 10 mM) and a non-incubated (NI, at the start of the incubation, no fatty acid) and an incubated (I, at the end of the incubation, no fatty acid) negative control group. Each reaction medium was made of 1 ml of inoculum, 1 g of synthetic feed and added with 9 ml of buffer solution. Plating was done in four (each incubation plated in duplicate in one ring-plate containing 7 × 2 rings each for the different dilutions, according to Van Der Heyde and Henderickx (1963) . Incubations were done for 4 hr at 37°C in a shaking warm water bath.
At start and after incubation, bacterial counts were done immediately on selective media (viable counts, log10 colony-forming units (CFU)/ml) using the ring-plate technique according to Van Der Heyde and Henderickx (1963) . Samples taken from the incubation media were thereafter serially diluted (10×) using a sterile peptone solution (1 g peptone, 0.4 g agar and 8.5 g NaCl/L distilled water). Immediately thereafter, plating was done in duplo within the ring-plate technique. The selective medium for E. coli (Oxoid, Basingstoke, UK) used was Eosin Methylene Blue (EMB) agar (only greenish metallic), and incubations were done in aerobic conditions for 24 hr at 37°C.
| LPS-challenge trial
| Piglets and management
The trial was performed at Kasetsart University (Kampaengsaen, 
| Treatments
| LPS-challenge trial
| Sampling and data collection
Non-challenged piglets' initial and final body weight were measured, and feed intake (FI) was recorded daily (Days 1-42). At Day 42, blood was sampled from all challenged piglets (jugular vein) and piglets were euthanized. Blood samples were centrifuged (3,000 g, 5 min, 4°C), and serum was collected and stored at -80°C. Serum IgA was determined using a porcine IgA ELISA kit (Innovative Research, Novi, Michigan, USA). Digestive tract samples of jejunum and ileum were collected for histological examination of crypt depth, villus height, IgA-positive plasma cells and goblet cell as done by Jaeger, Lamar, Cline, and Cardona (1990) and Nuñez et al. (1996) . For each type of tissue, 10 measurements were done. The villus height:crypt depth ratio (V:C) was calculated. IgA-positive plasma cells and goblet cells were counted according to Brown et al. (2006) in 10 randomly selected villi per tissue sample.
| Data analysis
The dietary contents of the feed samples were chemically ana- as the experimental unit. Differences in means were determined by Duncan's New Multiple Range Test.
| RE SULTS
| In vitro analysis
The starting E. coli count was about 10 3 CFU/g (Figure 1 ). The nonincubated control and incubated control showed E. coli growth (Figure 1 ). At all C6 concentrations (10, 12 and 15 mM) and C8
(12 mM), E. coli did not grow at pH = 3 and pH = 5. C10 (15 mM) reduced E. coli to 0 CFU at pH = 3 (gastric condition), but not at pH = 5
(duodenal condition).
| In vivo trial
| Dietary contents and piglet performance
The diets (MCT6/8 and AGP) were iso-caloric and iso-nitrogenous and had a similar nutritional content ( 
| LPS challenge and treatment effects in jejunum and ileum
Villus height and crypt depth
Considering the challenge, NC (saline solution) had higher jejunal and ileal villi than LPS-challenged piglets (p < 0.05) ( Considering the treatment, no important difference was seen in villus height and crypt depth between MCT6/8 and AGP.
Significant differences were seen in two cases: MCT6/8-supplemented piglets had higher ileal villi than AGP (p < 0.05) when they were challenged with LPS. Also, MCT6/8-treated piglets had deeper jejunal crypts than AGP when they were challenged with saline (NC).
The villus height:crypt depth ratio (V:C) in the jejunum and ileum did not show much variation (Table 3 ). In the jejunum, MCT6/8 piglets had a lower V:C than AGP (p < 0.05) when challenged with saline and this corresponds to the deeper jejunal crypts (p < 0.05) as opposed to a non-significant difference in villus height in MCT6/8 compared to AGP described above. In the jejunum also, MCT6/8 piglets show a higher V:C when challenged with LPS than saline. In the ileum, LPS-challenged piglets supplemented with MCT6/8 had a higher (p < 0.05) V:C than saline challenged piglets.
Serum IgA, IgA-positive plasma and goblet cell count
Considering the challenge, serum IgA was higher in LPS than NC (p < 0.01) and averaged 481.5 ± 5.0 and 399.8 ± 11.8 ng/ml respectively (results not shown). This difference was seen in both MCT6/8
and AGP-supplemented piglets.
Considering the treatment, MCT6/8-supplemented piglets had higher serum IgA than AGP, and this difference was significant when they were challenged with LPS (p < 0.01) ( Table 4 ). MCT6/8-supplemented piglets also showed higher serum IgA than AGP when they were challenged with saline (NC), but in this case, the difference was not significant (p = 0.13).
Differences in IgA-positive plasma cell number were more pronounced in the jejunum compared to the ileum (Table 5) Considering the treatment, MCT6/8-supplemented piglets had a F I G U R E 1 Effect of C6, C8 and C10 medium-chain fatty acid concentrations during in vitro intestinal digestion simulation at different pH (pH = 3, gastric) and (pH = 5; duodenal) on Escherichia coli growth compared to a non-incubated (NI, no fatty acids added, at the start of the incubation) and incubated (I, no fatty acids added, at the end of the incubation) negative control (4 hr, 37°C) Differences in goblet cell counts were more pronounced in the jejunum compared to the ileum (Table 6 ). In the jejunum, considering the challenge, NC and LPS had a similar goblet cell count when supplemented with MCT6/8 (and this is similar to the jejunal plasma cell count described above). NC had a lower jejunal goblet cell count than LPS when piglets were supplemented with AGP. Considering the treatment, MCT6/8-supplemented piglets had a higher jejunal goblet cell count than AGP when they were challenged with saline (NC) 
| D ISCUSS I ON
In weaning piglets, anti-microbials are mainly applied to combat diarrhoea from coliform overgrowth (Callens et al., 2012) . ETEC is the major cause of economic loss due to piglet morbidity and mortality and the extra cost of care and medicinal treatment. Wegener, 2012 ). An AMR study by Callens et al. (2015) demonstrated that sow anti-microbial treatments around parturition can select for E. coli AMR in the offspring, and this will persists throughout the pigs' life (Gibbons et al., 2016) . The present study investigated a non-medicinal support by MCG for proper weaning piglet productivity in the absence of pharmaceuticals.
The action of C6, C8 and C10 against E. coli was assessed in vitro, giving a fast screening of most potent anti-microbial fatty acids. C6
and C8 inhibited growth of E. coli completely when gastric (pH = 3) or duodenal (pH = 5) conditions were simulated. C10 reduced E. coli to 0 CFU at pH = 3 but not at pH = 5. This is in accordance with Skrivanová and Marounek (2007) on enteropathogenic rabbit E. coli.
There, the in vitro anti-microbial activity of C6, C8 and C10 was pH-dependent, with a lower bactericidal activity of capric acid, C10, at pH = 6.5 than pH = 5.3. This is also in accordance with a former study by Skřivanová, Savka, and Marounek (2004) on Salmonella. At pH = 6.3-6.6, a minority of Salmonella (6%) survived with C8 (1 mg/ ml; 30 min), where pH = 5.2-5.3 gave a non-detectable concentration of viable cells (Skřivanová et al., 2004) . The present study also
shows that the longest medium-chain fatty acid tested (C10) tended to be less active than the smaller molecules C6 and C8, at duodenal pH conditions (pH = 5).
This corresponds well with the findings of Van Immerseel et al. TA B L E 6 Goblet cell count (cells/field † ) ±SEM in jejunum and ileum in piglets fed diets supplemented with AGP or MCT6/8 and challenged with NaCl (NC) or LPS Gram-negative bacteria in vitro. Also at highest C12 concentration of 1%, no complete inhibition was seen (20 hr, 41.5°C, pH = 5).
Also, the concentration of fatty acids determines the anti-microbial activity. In the present in vitro study, 12 mM but also 10 mM of C6 performed better against E. coli than a 12 mM C10. This C8 activity was also demonstrated by Messens et al. (2010) and Skřivanová et al. (2004) . Messens et al. (2010) used a more profound simulation of the intestine, by means of an in vitro continuous culture system simulating the porcine caecal microbiota. There, Na caprylate (C8, 15 mM) significantly reduced E. coli and Salmonella, and to a lesser extent also Na caproate (C6, 15 mM) and Na caprinate (C10, 15 mM) (Messens et al., 2010) . In an in vitro bacterial culture with glucose, C8 (6 mM) inhibited Salmonella (S. enteritidis, S. infantis and S. typhimurium) glucose utilization, where no effects were seen for C10 and C6 at the same (6 mM) or at a higher (30 mM) concentration (Skřivanová et al., 2004) . The fact that no distinct effects were demonstrated for C6 in both studies could be due to differences in degree of ionization, solubility and form (as acid or as salt) of the medium-chain fatty acids in watery systems at a given pH (Dr. N.
Dierick, Ghent University, personal communication).
Our results are completely in line with in vitro data by Boyen et al. (2008) and Van Immerseel et al. (2004) , where C6 and C8 are demonstrated as the most potent medium-chain fatty acids to act against S. Typhimurium. C6 (2 mM) and C8 (2 mM) were stronger than C10 (2 mM) in reducing the expression of virulence genes fimA and hilA in a growing bacterial culture. It was suggested that this lowered the cell invasion of the porcine intestinal epithelial cell line cells by S. Typhimurium (Boyen et al., 2008) . C6 and C8 (5, 10 and 15 mM) were also bacteriostatic for Salmonella serovar Enteritidis 76Sa88 in Luria-Bertani culture medium, where C10 showed this effect only at highest concentrations tested (10 and 15 mM) (Van Immerseel et al., 2004) . C8 also completely inactivated S. Enteritidis in autoclaved chicken caecal content after a 24-hr incubation (Vasudevan et al., 2005) . These fatty acid concentrations and their effects against Salmonella correspond well to the concentrations and actions of C6, C8 and C10 on E. coli in the present study.
C6 and C8 were combined in a medium-chain glyceride concept is therefore suggested that MCT6/8 has anti-microbial potency and supports piglet productivity in these trial facilities. Also, others reported on the antibacterial effects of medium-chain fatty acids (2.5% MCT oil with or without exogenous lipase in the diet) on the main fore-gut flora compounds of piglets, including E. coli (Dierick et al., 2002b) . Feeding C8 (0.3%, uncoated) reduced E. coli counts in the jejunum and caecum of weaning piglets compared to a negative control group (Hanczakowska, Świątkiewicz, Wiśniewska, & Okoń, 2016) . A C6 feed supplement (0.3%, uncoated) decreased S. Enteritidis colonization of the caeca and internal organs in broilers infected Day 1 and sampled Day 8 (Van Immerseel et al., 2004) . On the contrary, C8 (0.3%, coated) had no influence on the faecal shedding and intestinal colonization of 6-week-old piglets experimentally infected with S. Typhimurium, sampled Day 4 postinfection. (Boyen et al., 2008) . It needs to be emphasized that these in vivo experiments included the free fatty acids at a medium to high dosage rate of 0.3%. The MCG formulation used in the present study was dosed less (0.176%) and resulted in similar piglet performance as for AGP. Decuypere and Dierick (2003) reported an increased daily weight gain (+10%) and reduced feed conversion rate (-3%) in post-weaning piglets due to feed supplemented with 2.5% MCT oil with or without exogenous lipase. This growth promoting effect of MTC/MCG is suggested to originate from the gut microbial regulation on the one hand and the steering of the gut ecosystem on the other (Dierick et al., 2002a (Dierick et al., , 2002b .
For deeper insight in the MCT6/8 mode of action, gut health and immune-related parameters were studied. It is demonstrated that the LPS challenge shortens the piglets' jejunal and ileal villi and un-deepens the crypts and this was not seen in NC. This suggests that an intravenous LPS administration has a direct impact on gut health, gut architecture and the digestive capacity. These findings correspond with Qi, ke, Wu, Xu, and Wei, (2014) , where E. coli-LPS was administered intraperitoneally in post-weaning piglets (21 days of age). That challenge significantly reduced the length of both jejunal and ileal villi as opposed to intraperitoneal administered saline.
However, MCT6/8 supplementation to LPS-challenged piglets resulted in higher villi than AGP, which is significant in the ileum and numerical in the jejunum. Although histo-morphology in the ileum is less easy to read due to the presence of ileal GALT tissue, this suggests that in-feed MCT6/8 is able to alleviate the intestinal injury that is provoked by LPS. On the contrary, C8 (0.3%, uncoated), as a free fatty acid, had no effects on jejunal villi width or crypt depth in the piglet study by Hanczakowska et al. (2016) . The increase in villus height by MCT6/8 compared to AGP was not seen in NC piglets.
Adding 5% Cuphea seeds, a natural and rich source of MCT oil (25% w/w), in combination with exogenous lipase, to the diet of piglets, significantly improved performances and increased the villus height/ crypt depth ratio and decreased the number of intra-epithelial lymphocytes in the small intestine . Ishii et al. (2009) gavaged unchallenged rats a C8-triglyceride at a high dosage of 5 g/ kg BW per day (approximately 10× the dose of MCT6/8 in the present study). This resulted in an increased jejunal and ileal enterocyte proliferation compared to a control group (corn oil, 5 g/kg BW per day). Thus, a dose-response effect of MCG on gut architecture can be suggested. This could explain why in the present study, dosing less than 2 kg per ton of feed, the villus height:crypt depth ratio was unambiguous.
Serum IgA was consistently higher when piglets were supplemented with MCT6/8 than AGP. This was the case in LPS-challenged piglets as well as NC. Serum IgA functions as a second line of defence by eliminating pathogens that crossed mucosae, where secretory (mucosal) IgA is a first line of defence against invasion by ingested pathogens at the mucosae (Levast, Berri, Wilson, Meurens, & Salmon, 2014; Woof & Kerr, 2004) . The level of specific serum IgA and intestinal secretory IgA is closely related (Cerutti & Rescigno, 2008) . The ileal secretory IgA expression increased in rats intravenously challenged with LPS and gavaged a C8-triglyceride (5 g kg per day) compared to NC (Kono et al., 2004) . Although our dosage rate was 10 times lower, and animals were sampled once, the effects of MCT6/8 to elevate serum IgA were consistent over treatment groups. The protective action of IgA was profoundly explored by Virdi et al. (2013) . They developed designer IgA that are produced by in-feed seeds, which protect weaned piglets against ETEC infection. An increase in serum IgA in challenged conditions using in-feed MCT6/8 thus can be an aid to enhance the animal's defence system and protection against ETEC. Also, the jejunal IgA-positive plasma cell counts were higher in MCT6/8-supplemented piglets compared to AGP and this was seen in LPS-challenged piglets as well as NC. On the other hand, lower IgA levels were seen in weaning piglets orally challenged with ETEC and fed spray-dried plasma (6% of compound feed) (Bosi et al., 2004) . This most likely occurred because of the inhibition of ETEC adhesion by plasma glycoproteins (Sanchez et al., 1993) . In the present study, however, the challenge was intravenously administered, and, no specific receptor interactions were targeted or further investigated.
Piglets challenged with LPS had a higher goblet cell count when supplemented with MCT6/8 than with AGP. This difference was significant in the jejunum but not in the ileum. This is in accordance with the increased goblet cell proliferation in rats using a C8-triglyceride (Ishii et al., 2009) . Mucus produced by goblet cells mediates the communication of enterocytes with the immune system and the other way around. Mucus is an important line of protection against luminal risks (Pelaseyed et al., 2014) , and its composition depends on the composition of the intestinal microbiota (Johansson et al., 2011; Rodríguez-Piñeiro, 2013; Rodríguez-Piñeiro & Johansson, 2015) . Therefore, an increase in mucus secretory cells by in-feed MCT6/8 suggests a higher intestinal protection.
| CON CLUS IONS
MCT6/8 supplementation at a dosage of 1.76 kg/ton feed supports piglet performance parameters as using the anti-microbial growth promoter (AGP) Quixalud in presented experimental settings. In LPS-challenged conditions, MCT6/8 was shown to increase jejunal villus height, which was not shown in AGP piglets. Additional intestinal effects of MCT6/8 in LPS-challenged conditions are the higher number of jejunal and ileal plasma cells and jejunal goblet cells as well as higher serum IgA than AGP. Consequently, MCT6/8 is proposed as an in-feed gut support for post-weaning piglets, in the absence of anti-microbials. This is suggested to come from a direct anti-microbial action as well as an indirect effect on different immune parameters. Consequently, MCT6/8 aids in well-performing, yet non-medicinal weaning piglet production.
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